89Zr-AMG211 PET Imaging Study
NCT02760199
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Advanced Gastrointestinal Cancer
Interventions
DRUG:
89Zr-AMG211
DEVICE:
89-ZrAMG211 PET
Sponsor
University Medical Center Groningen